P/E ratio for Titan Medical (TMD.TO)
P/E ratio as of May 2024 (TTM): -0.1379
According to Titan Medical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.137931. At the end of 2022 the company had a P/E ratio of -1.74.
P/E ratio history for Titan Medical from 2011 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -1.74 | -61.58% |
| 2021 | -4.52 | -4.19% |
| 2020 | -4.72 | 1193.89% |
| 2019 | -0.3650 | -58.98% |
| 2018 | -0.8897 | -57.99% |
| 2017 | -2.12 | 41.18% |
| 2016 | -1.50 | -21.05% |
| 2015 | -1.90 | -77.83% |
| 2014 | -8.57 | 14.31% |
| 2013 | -7.50 | -24.63% |
| 2012 | -9.95 | 121.45% |
| 2011 | -4.49 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.